News

Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302

CARLSBAD, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on…

2 years ago

Ozop Energy Solutions, Inc. to Report Substantial Revenue Growth for Q2 2022 Over 2021

Warwick, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC), is pleased to announce that it expects…

2 years ago

TELUS Health reaches milestone – supports two million Canadians with access to their own digital personal health record

Since launching in Western Canada in 2019, TELUS Health’s Personal Health Record (PHR) solution has seen rapid growth helping more…

2 years ago

Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers

First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic effects…

2 years ago

The Lancet Gastroenterology & Hepatology Publishes Data from Albireo’s Landmark PEDFIC 1 Study of Bylvay® (odevixibat) Treatment in PFIC

First successful global gold standard pediatric Phase 3 trial ever conducted in cholestatic liver disease PEDFIC 1 & 2 studies…

2 years ago

POINT Biopharma to Participate in Upcoming Investor Conferences

INDIANAPOLIS, July 06, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating…

2 years ago

T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results

Implemented expense reductions including headcount during the second quarterLEXINGTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO),…

2 years ago

Zacks Places Share Value of ABVC BioPharma at $9.50

FREMONT, CA, July 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical…

2 years ago

Quoin Pharmaceuticals Announces Opening of First Clinical Site for Netherton Syndrome Clinical Study

Three Arm, Randomized, Double-Blind, Vehicle Controlled Study Will Test Two Doses of QRX003 Versus VehicleASHBURN, Va., July 06, 2022 (GLOBE…

2 years ago

Evoke Pharma Expands IP Portfolio with Addition of Canadian Patent Covering GIMOTI Method of Use

SOLANA BEACH, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily…

2 years ago